https://www.selleckchem.com/pr....oducts/salinosporami
Purpose The present study aimed to investigate the efficacy and severity of adverse effects of HCAG and CAG re-induction chemotherapy in elderly low- and intermediate-risk group patients diagnosed with acute myeloid leukemia (AML) following induction failure. Methods A total of 94 AML patients were enrolled in the study, of whom 46 were treated with HCAG chemotherapy, while 48 were treated with CAG chemotherapy. Result The complete remission (CR) was 39.6% in the patients with HCAG, while the CR was 33.3% in
Like
Comment
Share
